Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAMES-PILOT: Glyburide in Severe Stroke
NCT01268683Phase 2Completed
- Sponsor
- Remedy Pharmaceuticals
- Start
- May 2011
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glibenclamide in ischemic stroke, sponsored by Remedy Pharmaceuticals. Started May 2011; status: completed.
02
Drugs
glibenclamide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01268683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01268683.